Concord Medical Services Holdings Limited
CCM
$7.68
-$0.5247-6.40%
NYSE
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 9.76% | 29.95% | 9.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 9.76% | 29.95% | 9.63% |
| Cost of Revenue | -- | -- | -5.70% | 13.14% | 10.79% |
| Gross Profit | -- | -- | 52.61% | 36.58% | -15.99% |
| SG&A Expenses | -- | -- | -1.19% | -2.13% | -7.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -4.01% | 7.20% | 3.36% |
| Operating Income | -- | -- | 16.24% | 11.93% | 2.55% |
| Income Before Tax | -- | -- | 36.60% | -19.09% | -32.54% |
| Income Tax Expenses | -- | -- | 65.53% | -621.17% | -721.25% |
| Earnings from Continuing Operations | -- | -- | 33.98% | -8.41% | -21.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -20.83% | -26.54% | -12.50% |
| Net Income | -- | -- | 41.64% | -45.91% | -56.42% |
| EBIT | -- | -- | 16.24% | 11.93% | 2.55% |
| EBITDA | -- | -- | 23.61% | 18.80% | 7.76% |
| EPS Basic | -- | -- | 41.64% | 49.01% | 46.66% |
| Normalized Basic EPS | -- | -- | -46.41% | -4.80% | -4.80% |
| EPS Diluted | -- | -- | 41.61% | 48.94% | 53.32% |
| Normalized Diluted EPS | -- | -- | -46.41% | -4.80% | -4.80% |
| Average Basic Shares Outstanding | -- | -- | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -- | -- | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |